SCHEMBL1678341

SCHEMBL1678341

CCC(CC)(CC)NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL29101364 0.96 TSHR (0.31)
Bicarbonate SCHEMBL31411211 0.87 FFAR3 (0.37)
Oxalic Acid SCHEMBL11125463 0.84 ALOX15 (0.37)
SCHEMBL31131462 0.82
SCHEMBL1678760 0.79
SCHEMBL31389348 0.79
SCHEMBL5180978 0.79
SCHEMBL3401104 0.79
SCHEMBL12408046 0.79
SCHEMBL19268291 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-221432150-U Catalyst recovery system for p-nitrodiethyl ether 江苏中丹化工技术有限公司 2024-07-30 CN disclosed
CN-110233290-A Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery using same 三菱化学株式会社 2019-09-13 CN disclosed
CN-104966849-B Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery using same 三菱化学株式会社 2019-06-07 CN disclosed
WO-2017072722-A1 CGRP RECEPTOR ANTAGONISTS HEPTARES THERAPEUTICS LIMITED (GB) 2017-05-04 WO disclosed
CN-104167564-B Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery 三菱化学株式会社 2017-04-12 CN disclosed
CN-104966849-A Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery using same MITSUBISHI CHEM CORP 2015-10-07 CN disclosed
CN-102623747-B Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery using same MITSUBISHI CHEM CORP 2015-02-18 CN disclosed
CN-101884629-B Controlled release preparation TAKEDA PHARMACEUTICAL 2013-08-21 CN disclosed
CN-1713897-B Controlled release formulations TAKEDA CHEMICAL INDUSTRIES LTD 2012-07-04 CN disclosed
CN-102089269-A Process for the separation of carboxylic acids bearing at least one halogen atom in salified form RHODIA OPERATIONS 2011-06-08 CN disclosed
US-7923573-B2 Benzene compound having 2 or more substituents DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-04-12 US disclosed
CN-101884629-A Controlled release preparation TAKEDA PHARMACEUTICAL 2010-11-17 CN disclosed
US-20080255111-A1 Tissue Factor Production Inhibitor SANKYO COMPANY LIMITED (JP) 2008-10-16 US disclosed
US-20080004301-A1 Benzene Compound Having 2 or More Substituents DAIICHI SANKYO COMPANY, LIMITED (JP) 2008-01-03 US disclosed
EP-1806332-A1 BENZENE COMPOUND HAVING 2 OR MORE SUBSTITUENTS Daiichi Sankyo Company, Limited (JP) 2007-07-11 EP disclosed
EP-1764075-A1 TISSUE FACTOR PRODUCTION INHIBITOR Sankyo Company, Limited (JP) 2007-03-21 EP disclosed
CN-1713897-A Controlled release formulations TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2005-12-28 CN disclosed
CN-1678315-A Prodrugs of imidazole derivatives as proton pump inhibitors for the treatment of e.g. peptic ulcers TAKEDA PHARMACEUTICAL (JP) 2005-10-05 CN disclosed